Published in J Virol on January 01, 1988
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J Virol (1993) 3.46
GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J Virol (1992) 2.37
The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J Virol (1994) 2.17
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol (1994) 1.83
Determination of the mutation rate of a retrovirus. J Virol (1988) 1.75
A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infection and binds directly to ALSV-A. J Virol (1994) 1.54
Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection. J Virol (1997) 1.40
Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol (1990) 1.29
Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J Virol (1993) 1.25
Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci U S A (1995) 1.18
The receptor for the subgroup C avian sarcoma and leukosis viruses, Tvc, is related to mammalian butyrophilins, members of the immunoglobulin superfamily. J Virol (2005) 1.17
Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo. J Virol (1999) 1.09
Genetic mapping of the cloned subgroup A avian sarcoma and leukosis virus receptor gene to the TVA locus. J Virol (1998) 1.08
Selection of an avian retrovirus mutant with extended receptor usage. J Virol (1997) 1.05
Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor. J Virol (2001) 1.05
Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex. J Virol (2002) 1.02
Genome structure and expression of the ev/J family of avian endogenous viruses. J Virol (1999) 1.01
Packaging cells for avian leukosis virus-based vectors with various host ranges. J Virol (1992) 1.00
The unique envelope gene of the subgroup J avian leukosis virus derives from ev/J proviruses, a novel family of avian endogenous viruses. J Virol (1998) 0.98
Development of a loop-mediated isothermal amplification assay for rapid detection of subgroup J avian leukosis virus. J Clin Microbiol (2010) 0.93
Endogenous expression of ASLV viral proteins in specific pathogen free chicken embryos: relevance for the developmental biology research field. BMC Dev Biol (2010) 0.91
Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions. J Virol (2003) 0.91
Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J Virol (2005) 0.90
Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85. J Virol (1991) 0.88
Independent isolates of the emerging subgroup J avian leukosis virus derive from a common ancestor. J Virol (1998) 0.87
Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain. J Virol (2000) 0.85
Molecular and biological properties of c-mil transducing retroviruses generated during passage of Rous-associated virus type 1 in chicken neuroretina cells. J Virol (1990) 0.83
Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production. Oncotarget (2016) 0.79
Inversion of a chicken ets-1 proto-oncogene segment in avian leukemia virus E26. J Virol (1993) 0.79
The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion. PLoS One (2007) 0.78
Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses. J Virol (2014) 0.77
Avian sarcoma leukosis virus receptor-envelope system for simultaneous dissection of multiple neural circuits in mammalian brain. Proc Natl Acad Sci U S A (2015) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
SV40-transformed simian cells support the replication of early SV40 mutants. Cell (1981) 34.67
Nucleotide sequence of Rous sarcoma virus. Cell (1983) 17.80
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE. Exp Cell Res (1963) 11.23
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol (1981) 9.51
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31
Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology (1969) 6.24
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci U S A (1973) 5.20
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Mapping of biological functions on RNA of avian tumor viruses: location of regions required for transformation and determination of host range. Proc Natl Acad Sci U S A (1975) 4.01
Glycoprotein components of avian and murine RNA tumor viruses. Virology (1970) 3.92
Characteristics of two new avian tumor virus subgroups. Virology (1969) 3.81
Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85. Cell (1986) 3.80
Location of envelope-specific and sarcoma-specific oligonucleotides on RNA of Schmidt-Ruppin Rous sarcoma virus. Proc Natl Acad Sci U S A (1976) 3.73
Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus. Cell (1981) 3.26
Recovery of a new virus from apparently normal chick cells by infection with avian tumor viruses. Proc Natl Acad Sci U S A (1970) 2.99
Determining factor in the capacity of Rous sarcoma virus to induce tumors in mammals. Proc Natl Acad Sci U S A (1966) 2.86
Immunological relationships among envelope antigens of avian tumor viruses. Virology (1966) 2.67
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity. Virology (1983) 2.53
Complete sequence of the Rous sarcoma virus env gene: identification of structural and functional regions of its product. J Virol (1983) 2.53
Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene. Mol Cell Biol (1982) 2.51
Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J Virol (1986) 2.42
Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology (1984) 2.38
Subunit structure of the glycoprotein complex of avian tumor virus. J Virol (1976) 2.38
Molecular basis of host range variation in avian retroviruses. J Virol (1985) 2.19
Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol (1972) 2.17
env genes of avian retroviruses: nucleotide sequence and molecular recombinants define host range determinants. Virology (1986) 2.11
The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. II. Early steps of infection by RSV of cells under conditions of interference. Virology (1966) 2.11
Polypeptides of avian RNA tumor viruses. IV. Components of the viral envelope. Virology (1972) 2.09
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Nucleotide sequence relationships between the genomes of an endogenous and an exogenous avian tumor virus. J Virol (1978) 2.01
Evidence that a precursor glycoprotein is cleaved to yield the major glycoprotein of avian tumor virus. J Virol (1977) 1.70
The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev Biol (1983) 1.64
Analysis of precursors to the envelope glycoproteins of avian RNA tumor viruses in chicken and quail cells. J Virol (1977) 1.61
The generation of the two envelope glycoproteins of Rous sarcoma virus from a common precursor polypeptide. Virology (1978) 1.49
The nature of gliomas as revealed by animal experimentation. Am J Pathol (1955) 1.42
Intracellular precursors to the major glycoprotein of avian oncoviruses in chicken embryo fibroblasts. J Virol (1978) 1.37
GENETIC RESISTANCE TO ROUS SARCOMA VIRUS IN EMBRYO CELL CULTURES AND EMBRYOS. Virology (1963) 1.30
Synthesis and processing of avian sarcoma virus glycoproteins. Virology (1978) 1.29
Two loci controlling genetic cellular resistance to avian leukosis-sarcoma viruses. J Virol (1967) 1.27
Strain-specific antigen of the avian leukosis sarcoma virus group. I. Isolation and immunological characterization. Virology (1970) 1.22
DIFFERENCES BETWEEN HIGHLY INBRED LINES OF CHICKENS IN THE RESPONSE TO ROUS SARCOMA VIRUS OF THE CHORIOALLANTOIC MEMBRANE AND OF EMBRYONIC CELLS IN TISSUE CULTURE. Virology (1964) 1.20
A very sensitive biochemical assay for detecting and quantitating avian oncornaviruses. Virology (1977) 1.11
Virus envelope markers in mammalian tropism of avian RNA tumor viruses. J Virol (1975) 1.09
Further findings on the induction of tumors by Rous sarcoma in rats and on the Rous virus-producing capacity of one of the induced tumours (XC) in chicks. Folia Biol (Praha) (1962) 0.96
Sites of recombination between the transforming gene of avian myeloblastosis virus and its helper virus. Virology (1985) 0.85
Evidence for the possible existence of two envelope antigenic determinants and corresponding cell receptors for avian tumor viruses. Virology (1969) 0.78
X-ray intensifying screens greatly enhance the detection by autoradiography of the radioactive isotopes 32P and 125I. Anal Biochem (1978) 10.28
CFTR as a cAMP-dependent regulator of sodium channels. Science (1995) 6.50
Complete mutagenesis of the HIV-1 protease. Nature (1989) 5.16
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med (1995) 4.30
Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol (1990) 4.22
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol (1994) 3.95
Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci U S A (1981) 3.82
Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science (1987) 3.46
Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A (1983) 3.41
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science (1996) 3.38
The nucleotide sequence of an untranslated but conserved domain at the 3' end of the avian sarcoma virus genome. Nucleic Acids Res (1980) 3.16
Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J Virol (1993) 2.96
Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol (1993) 2.94
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc Natl Acad Sci U S A (1991) 2.80
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol (2001) 2.79
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet (1992) 2.79
Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology (2001) 2.74
Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res Hum Retroviruses (1989) 2.62
Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci U S A (1994) 2.59
Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus. J Virol (1982) 2.53
The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides. J Virol (1982) 2.51
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci U S A (1994) 2.48
V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol (1993) 2.27
A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med (1994) 2.25
Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem (1991) 2.11
env genes of avian retroviruses: nucleotide sequence and molecular recombinants define host range determinants. Virology (1986) 2.11
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09
Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J Virol (1997) 2.04
Nuclease mechanism of the avian retrovirus pp32 endonuclease. J Virol (1986) 2.01
Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol (1993) 1.77
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases. J Virol (1989) 1.66
tRNATrp as primer for RNA-directed DNA polymerase: structural determinants of function. J Biol Chem (1979) 1.62
Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activity. AIDS Res Hum Retroviruses (1991) 1.56
Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci U S A (1996) 1.56
Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity (1997) 1.51
A new pathway in the generation of defective retrovirus DNA. J Virol (1985) 1.44
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics. Proc Natl Acad Sci U S A (2001) 1.41
The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv Exp Med Biol (1998) 1.41
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Virology (1997) 1.36
Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J Virol (2001) 1.33
Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants. J Virol (1990) 1.31
The terminal redundancy of the retrovirus genome facilitates chain elongation by reverse transcriptase. J Biol Chem (1981) 1.28
Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther (2006) 1.25
Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther (2000) 1.24
Novel human bronchial epithelial cell lines for cystic fibrosis research. Am J Physiol Lung Cell Mol Physiol (2008) 1.24
Avian retrovirus RNA-directed DNA synthesis by purified reverse transcriptase. Covalent linkage of RNA to plus strand DNA. Biochem Biophys Res Commun (1980) 1.22
Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease. J Virol (1997) 1.22
Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection. J Virol (2000) 1.21
Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum Gene Ther (1992) 1.20
A genetic approach for identifying critical residues in the fingers and palm subdomains of HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (1998) 1.19
Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1. Nucleic Acids Res (1995) 1.19
Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants. Proc Natl Acad Sci U S A (1997) 1.17
Complete mutagenesis of protein coding domains. Methods Enzymol (1991) 1.16
Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol (1998) 1.10
Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Ther (2005) 1.09
Genetic variability of the human immunodeficiency virus: statistical and biological issues. Annu Rev Genet (1994) 1.07
The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta. J Immunol (1995) 1.04
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity. Biomed Biochim Acta (1991) 1.04
The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance. AIDS Res Hum Retroviruses (1999) 1.04
DNA intermediates in the replication of retroviruses are structurally (and perhaps functionally) related to transposable elements. Cold Spring Harb Symp Quant Biol (1981) 0.99
Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells. Proc Natl Acad Sci U S A (1999) 0.99
Reverse transcription of avian myeloblastosis virus 35S RNA. Early synthesis of plus strand DNA of discrete size in reconstructed reactions. Nucleic Acids Res (1982) 0.99
Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy. Vaccine (1999) 0.99
3'-Azido-3'-deoxythymidine inhibits the replication of avian leukosis virus. J Virol (1987) 0.98
Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Hum Gene Ther (1994) 0.98
NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Ther (1997) 0.97
Structure of a replication intermediate in the synthesis of Rous sarcoma virus DNA in vivo. J Virol (1982) 0.97
Identification of a splice site mutation (2789 +5 G > A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis. Hum Mutat (1997) 0.97
Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrob Agents Chemother (1994) 0.96
Analysis of human immunodeficiency virus type 1 protease activity in eukaryotic and bacterial cells. Methods Enzymol (1994) 0.96
Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts. J Biol Chem (1993) 0.96
A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant. Virology (1995) 0.96
Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts. J Virol (1992) 0.93
An anomalous Ty1 structure attributed to an error in reverse transcription. Mol Cell Biol (1986) 0.93
Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol (2001) 0.93
Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions. J Biol Chem (1997) 0.93
Interaction of psoralen derivatives with the RNA genome of Rous sarcoma virus. Virology (1981) 0.92
Using HIV-1 sequence variability to explore virus biology. Virus Res (2001) 0.91
Design of retroviral expression vectors. Methods Mol Biol (1997) 0.90
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci U S A (1994) 0.90
Identification of temperature-sensitive mutants of the human immunodeficiency virus type 1 protease through saturation mutagenesis. Amino acid side chain requirements for temperature sensitivity. J Biol Chem (1994) 0.90
High-efficiency gene transfer to primary monkey airway epithelial cells with retrovirus vectors using the gibbon ape leukemia virus receptor. Hum Gene Ther (1993) 0.89
Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression. Nucleic Acids Res (1993) 0.89
Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats. Gene Ther (1995) 0.88
Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85. J Virol (1991) 0.88
Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia. Blood (2000) 0.88